[
  {
    "doc_id": "sec-edgar-8-k-2026-06-22-ef20076542-8k-htm",
    "title": "8-K – 2026-06-22 – ef20076542_8k.htm",
    "source": "SEC EDGAR",
    "source_class": "sec",
    "source_url": "https://www.sec.gov/Archives/edgar/data/1974640/000114036126025841/ef20076542_8k.htm",
    "date": "2026-06-22",
    "period": "2026-06-17",
    "form_type": "8-K",
    "report_key": null,
    "filename": "ef20076542_8k.htm",
    "text_chars": 8462,
    "sha256": "50f95b8b27f6ec79f1f644a34cebae282ce97836861cdfbc236c20a41e6364e1",
    "url": "/company/apogee-therapeutics-inc/documents/sec-edgar-8-k-2026-06-22-ef20076542-8k-htm",
    "absolute_url": "https://spela.port0.org/company/apogee-therapeutics-inc/documents/sec-edgar-8-k-2026-06-22-ef20076542-8k-htm",
    "txt_url": "/company/apogee-therapeutics-inc/documents/sec-edgar-8-k-2026-06-22-ef20076542-8k-htm/fulltext.txt",
    "absolute_txt_url": "https://spela.port0.org/company/apogee-therapeutics-inc/documents/sec-edgar-8-k-2026-06-22-ef20076542-8k-htm/fulltext.txt",
    "parts": [
      {
        "number": 1,
        "url": "/company/apogee-therapeutics-inc/documents/sec-edgar-8-k-2026-06-22-ef20076542-8k-htm/part-001.html",
        "chars": 8462
      }
    ]
  },
  {
    "doc_id": "sec-edgar-8-k-2026-06-22-ef20076505-8k-htm",
    "title": "8-K – 2026-06-22 – ef20076505_8k.htm",
    "source": "SEC EDGAR",
    "source_class": "sec",
    "source_url": "https://www.sec.gov/Archives/edgar/data/1974640/000114036126025844/ef20076505_8k.htm",
    "date": "2026-06-22",
    "period": "2026-06-18",
    "form_type": "8-K",
    "report_key": null,
    "filename": "ef20076505_8k.htm",
    "text_chars": 26507,
    "sha256": "9a812a5ed68ce73aa5044ed4df768ee3cc23a64cc0506c23f8c36cc614d4e306",
    "url": "/company/apogee-therapeutics-inc/documents/sec-edgar-8-k-2026-06-22-ef20076505-8k-htm",
    "absolute_url": "https://spela.port0.org/company/apogee-therapeutics-inc/documents/sec-edgar-8-k-2026-06-22-ef20076505-8k-htm",
    "txt_url": "/company/apogee-therapeutics-inc/documents/sec-edgar-8-k-2026-06-22-ef20076505-8k-htm/fulltext.txt",
    "absolute_txt_url": "https://spela.port0.org/company/apogee-therapeutics-inc/documents/sec-edgar-8-k-2026-06-22-ef20076505-8k-htm/fulltext.txt",
    "parts": [
      {
        "number": 1,
        "url": "/company/apogee-therapeutics-inc/documents/sec-edgar-8-k-2026-06-22-ef20076505-8k-htm/part-001.html",
        "chars": 26507
      }
    ]
  },
  {
    "doc_id": "sec-edgar-8-k-2026-06-12-apge-20260609-htm",
    "title": "8-K – 2026-06-12 – apge-20260609.htm",
    "source": "SEC EDGAR",
    "source_class": "sec",
    "source_url": "https://www.sec.gov/Archives/edgar/data/1974640/000119312526269650/apge-20260609.htm",
    "date": "2026-06-12",
    "period": "2026-06-09",
    "form_type": "8-K",
    "report_key": null,
    "filename": "apge-20260609.htm",
    "text_chars": 4316,
    "sha256": "6febecb740b8c2ca122d2f0c8b67a1875acf1cdc52f211c4bace1998e9b812df",
    "url": "/company/apogee-therapeutics-inc/documents/sec-edgar-8-k-2026-06-12-apge-20260609-htm",
    "absolute_url": "https://spela.port0.org/company/apogee-therapeutics-inc/documents/sec-edgar-8-k-2026-06-12-apge-20260609-htm",
    "txt_url": "/company/apogee-therapeutics-inc/documents/sec-edgar-8-k-2026-06-12-apge-20260609-htm/fulltext.txt",
    "absolute_txt_url": "https://spela.port0.org/company/apogee-therapeutics-inc/documents/sec-edgar-8-k-2026-06-12-apge-20260609-htm/fulltext.txt",
    "parts": [
      {
        "number": 1,
        "url": "/company/apogee-therapeutics-inc/documents/sec-edgar-8-k-2026-06-12-apge-20260609-htm/part-001.html",
        "chars": 4316
      }
    ]
  },
  {
    "doc_id": "sec-edgar-8-k-2026-05-27-tm2615568d2-8k-htm",
    "title": "8-K – 2026-05-27 – tm2615568d2_8k.htm",
    "source": "SEC EDGAR",
    "source_class": "sec",
    "source_url": "https://www.sec.gov/Archives/edgar/data/1974640/000110465926066575/tm2615568d2_8k.htm",
    "date": "2026-05-27",
    "period": "2026-05-26",
    "form_type": "8-K",
    "report_key": null,
    "filename": "tm2615568d2_8k.htm",
    "text_chars": 9909,
    "sha256": "3e119058884c861b41bcd70cc40ffd9dd3d3910526959b6fe08b9d132a60fbc3",
    "url": "/company/apogee-therapeutics-inc/documents/sec-edgar-8-k-2026-05-27-tm2615568d2-8k-htm",
    "absolute_url": "https://spela.port0.org/company/apogee-therapeutics-inc/documents/sec-edgar-8-k-2026-05-27-tm2615568d2-8k-htm",
    "txt_url": "/company/apogee-therapeutics-inc/documents/sec-edgar-8-k-2026-05-27-tm2615568d2-8k-htm/fulltext.txt",
    "absolute_txt_url": "https://spela.port0.org/company/apogee-therapeutics-inc/documents/sec-edgar-8-k-2026-05-27-tm2615568d2-8k-htm/fulltext.txt",
    "parts": [
      {
        "number": 1,
        "url": "/company/apogee-therapeutics-inc/documents/sec-edgar-8-k-2026-05-27-tm2615568d2-8k-htm/part-001.html",
        "chars": 9909
      }
    ]
  },
  {
    "doc_id": "sec-edgar-8-k-2026-05-27-tm2615568d1-8k-htm",
    "title": "8-K – 2026-05-27 – tm2615568d1_8k.htm",
    "source": "SEC EDGAR",
    "source_class": "sec",
    "source_url": "https://www.sec.gov/Archives/edgar/data/1974640/000110465926066572/tm2615568d1_8k.htm",
    "date": "2026-05-27",
    "period": "2026-05-27",
    "form_type": "8-K",
    "report_key": null,
    "filename": "tm2615568d1_8k.htm",
    "text_chars": 14240,
    "sha256": "e9f52f02aee95959b954f9974664867b0dc6773ba24255e2a3b1c832633dbdcf",
    "url": "/company/apogee-therapeutics-inc/documents/sec-edgar-8-k-2026-05-27-tm2615568d1-8k-htm",
    "absolute_url": "https://spela.port0.org/company/apogee-therapeutics-inc/documents/sec-edgar-8-k-2026-05-27-tm2615568d1-8k-htm",
    "txt_url": "/company/apogee-therapeutics-inc/documents/sec-edgar-8-k-2026-05-27-tm2615568d1-8k-htm/fulltext.txt",
    "absolute_txt_url": "https://spela.port0.org/company/apogee-therapeutics-inc/documents/sec-edgar-8-k-2026-05-27-tm2615568d1-8k-htm/fulltext.txt",
    "parts": [
      {
        "number": 1,
        "url": "/company/apogee-therapeutics-inc/documents/sec-edgar-8-k-2026-05-27-tm2615568d1-8k-htm/part-001.html",
        "chars": 14240
      }
    ]
  },
  {
    "doc_id": "sec-edgar-8-k-2026-05-11-apge-20260511-htm",
    "title": "8-K – 2026-05-11 – apge-20260511.htm",
    "source": "SEC EDGAR",
    "source_class": "sec",
    "source_url": "https://www.sec.gov/Archives/edgar/data/1974640/000119312526215683/apge-20260511.htm",
    "date": "2026-05-11",
    "period": "2026-05-11",
    "form_type": "8-K",
    "report_key": null,
    "filename": "apge-20260511.htm",
    "text_chars": 3710,
    "sha256": "366e91ea155b40f194dbd649d5a8670764fbc59756d055adcb13d59aabdb80db",
    "url": "/company/apogee-therapeutics-inc/documents/sec-edgar-8-k-2026-05-11-apge-20260511-htm",
    "absolute_url": "https://spela.port0.org/company/apogee-therapeutics-inc/documents/sec-edgar-8-k-2026-05-11-apge-20260511-htm",
    "txt_url": "/company/apogee-therapeutics-inc/documents/sec-edgar-8-k-2026-05-11-apge-20260511-htm/fulltext.txt",
    "absolute_txt_url": "https://spela.port0.org/company/apogee-therapeutics-inc/documents/sec-edgar-8-k-2026-05-11-apge-20260511-htm/fulltext.txt",
    "parts": [
      {
        "number": 1,
        "url": "/company/apogee-therapeutics-inc/documents/sec-edgar-8-k-2026-05-11-apge-20260511-htm/part-001.html",
        "chars": 3710
      }
    ]
  },
  {
    "doc_id": "sec-edgar-10-q-2026-05-11-apge-20260331-htm",
    "title": "10-Q – 2026-05-11 – apge-20260331.htm",
    "source": "SEC EDGAR",
    "source_class": "sec",
    "source_url": "https://www.sec.gov/Archives/edgar/data/1974640/000119312526215698/apge-20260331.htm",
    "date": "2026-05-11",
    "period": "2026-03-31",
    "form_type": "10-Q",
    "report_key": null,
    "filename": "apge-20260331.htm",
    "text_chars": 365772,
    "sha256": "1b6c38a1697a6533b05bf0e85dadd105712a268fdc06775cf4ef84cf10412e4a",
    "url": "/company/apogee-therapeutics-inc/documents/sec-edgar-10-q-2026-05-11-apge-20260331-htm",
    "absolute_url": "https://spela.port0.org/company/apogee-therapeutics-inc/documents/sec-edgar-10-q-2026-05-11-apge-20260331-htm",
    "txt_url": "/company/apogee-therapeutics-inc/documents/sec-edgar-10-q-2026-05-11-apge-20260331-htm/fulltext.txt",
    "absolute_txt_url": "https://spela.port0.org/company/apogee-therapeutics-inc/documents/sec-edgar-10-q-2026-05-11-apge-20260331-htm/fulltext.txt",
    "parts": [
      {
        "number": 1,
        "url": "/company/apogee-therapeutics-inc/documents/sec-edgar-10-q-2026-05-11-apge-20260331-htm/part-001.html",
        "chars": 177170
      },
      {
        "number": 2,
        "url": "/company/apogee-therapeutics-inc/documents/sec-edgar-10-q-2026-05-11-apge-20260331-htm/part-002.html",
        "chars": 178121
      },
      {
        "number": 3,
        "url": "/company/apogee-therapeutics-inc/documents/sec-edgar-10-q-2026-05-11-apge-20260331-htm/part-003.html",
        "chars": 10474
      }
    ]
  },
  {
    "doc_id": "sec-edgar-8-k-2026-04-24-apge-20260421-htm",
    "title": "8-K – 2026-04-24 – apge-20260421.htm",
    "source": "SEC EDGAR",
    "source_class": "sec",
    "source_url": "https://www.sec.gov/Archives/edgar/data/1974640/000119312526177288/apge-20260421.htm",
    "date": "2026-04-24",
    "period": "2026-04-21",
    "form_type": "8-K",
    "report_key": null,
    "filename": "apge-20260421.htm",
    "text_chars": 3165,
    "sha256": "0ca7d58b2068e0ccbe254b53a630fcc31aa400702baae934bef28e443ed59fd7",
    "url": "/company/apogee-therapeutics-inc/documents/sec-edgar-8-k-2026-04-24-apge-20260421-htm",
    "absolute_url": "https://spela.port0.org/company/apogee-therapeutics-inc/documents/sec-edgar-8-k-2026-04-24-apge-20260421-htm",
    "txt_url": "/company/apogee-therapeutics-inc/documents/sec-edgar-8-k-2026-04-24-apge-20260421-htm/fulltext.txt",
    "absolute_txt_url": "https://spela.port0.org/company/apogee-therapeutics-inc/documents/sec-edgar-8-k-2026-04-24-apge-20260421-htm/fulltext.txt",
    "parts": [
      {
        "number": 1,
        "url": "/company/apogee-therapeutics-inc/documents/sec-edgar-8-k-2026-04-24-apge-20260421-htm/part-001.html",
        "chars": 3165
      }
    ]
  },
  {
    "doc_id": "sec-edgar-8-k-2026-03-25-tm269761d1-8k-htm",
    "title": "8-K – 2026-03-25 – tm269761d1_8k.htm",
    "source": "SEC EDGAR",
    "source_class": "sec",
    "source_url": "https://www.sec.gov/Archives/edgar/data/1974640/000110465926034579/tm269761d1_8k.htm",
    "date": "2026-03-25",
    "period": "2026-03-24",
    "form_type": "8-K",
    "report_key": null,
    "filename": "tm269761d1_8k.htm",
    "text_chars": 5313,
    "sha256": "fe3c1aabb7eb1e8db7940b85e32c0a7ae1f8fbc20780a6ca5fe3ba08a07f7922",
    "url": "/company/apogee-therapeutics-inc/documents/sec-edgar-8-k-2026-03-25-tm269761d1-8k-htm",
    "absolute_url": "https://spela.port0.org/company/apogee-therapeutics-inc/documents/sec-edgar-8-k-2026-03-25-tm269761d1-8k-htm",
    "txt_url": "/company/apogee-therapeutics-inc/documents/sec-edgar-8-k-2026-03-25-tm269761d1-8k-htm/fulltext.txt",
    "absolute_txt_url": "https://spela.port0.org/company/apogee-therapeutics-inc/documents/sec-edgar-8-k-2026-03-25-tm269761d1-8k-htm/fulltext.txt",
    "parts": [
      {
        "number": 1,
        "url": "/company/apogee-therapeutics-inc/documents/sec-edgar-8-k-2026-03-25-tm269761d1-8k-htm/part-001.html",
        "chars": 5313
      }
    ]
  },
  {
    "doc_id": "sec-edgar-8-k-2026-03-23-tm269553d1-8k-htm",
    "title": "8-K – 2026-03-23 – tm269553d1_8k.htm",
    "source": "SEC EDGAR",
    "source_class": "sec",
    "source_url": "https://www.sec.gov/Archives/edgar/data/1974640/000110465926032950/tm269553d1_8k.htm",
    "date": "2026-03-23",
    "period": "2026-03-23",
    "form_type": "8-K",
    "report_key": null,
    "filename": "tm269553d1_8k.htm",
    "text_chars": 8120,
    "sha256": "91d33eb59987087e8590bf15e15cf129f6be1e931a4aad99e4f57461acb7e561",
    "url": "/company/apogee-therapeutics-inc/documents/sec-edgar-8-k-2026-03-23-tm269553d1-8k-htm",
    "absolute_url": "https://spela.port0.org/company/apogee-therapeutics-inc/documents/sec-edgar-8-k-2026-03-23-tm269553d1-8k-htm",
    "txt_url": "/company/apogee-therapeutics-inc/documents/sec-edgar-8-k-2026-03-23-tm269553d1-8k-htm/fulltext.txt",
    "absolute_txt_url": "https://spela.port0.org/company/apogee-therapeutics-inc/documents/sec-edgar-8-k-2026-03-23-tm269553d1-8k-htm/fulltext.txt",
    "parts": [
      {
        "number": 1,
        "url": "/company/apogee-therapeutics-inc/documents/sec-edgar-8-k-2026-03-23-tm269553d1-8k-htm/part-001.html",
        "chars": 8120
      }
    ]
  },
  {
    "doc_id": "sec-edgar-8-k-2026-03-02-apge-20260302-htm",
    "title": "8-K – 2026-03-02 – apge-20260302.htm",
    "source": "SEC EDGAR",
    "source_class": "sec",
    "source_url": "https://www.sec.gov/Archives/edgar/data/1974640/000197464026000001/apge-20260302.htm",
    "date": "2026-03-02",
    "period": "2026-03-02",
    "form_type": "8-K",
    "report_key": null,
    "filename": "apge-20260302.htm",
    "text_chars": 3715,
    "sha256": "0c96e83aa3e34509a17bb0cbd9e092d1e0a2c847d7fe561c26edd9359a3dd2f2",
    "url": "/company/apogee-therapeutics-inc/documents/sec-edgar-8-k-2026-03-02-apge-20260302-htm",
    "absolute_url": "https://spela.port0.org/company/apogee-therapeutics-inc/documents/sec-edgar-8-k-2026-03-02-apge-20260302-htm",
    "txt_url": "/company/apogee-therapeutics-inc/documents/sec-edgar-8-k-2026-03-02-apge-20260302-htm/fulltext.txt",
    "absolute_txt_url": "https://spela.port0.org/company/apogee-therapeutics-inc/documents/sec-edgar-8-k-2026-03-02-apge-20260302-htm/fulltext.txt",
    "parts": [
      {
        "number": 1,
        "url": "/company/apogee-therapeutics-inc/documents/sec-edgar-8-k-2026-03-02-apge-20260302-htm/part-001.html",
        "chars": 3715
      }
    ]
  },
  {
    "doc_id": "sec-edgar-10-k-2026-03-02-apge-20251231-htm",
    "title": "10-K – 2026-03-02 – apge-20251231.htm",
    "source": "SEC EDGAR",
    "source_class": "sec",
    "source_url": "https://www.sec.gov/Archives/edgar/data/1974640/000197464026000002/apge-20251231.htm",
    "date": "2026-03-02",
    "period": "2025-12-31",
    "form_type": "10-K",
    "report_key": null,
    "filename": "apge-20251231.htm",
    "text_chars": 627504,
    "sha256": "2b3f75f212149491252b7777c9b2fbcf457be175588982d62df061f3abeaef96",
    "url": "/company/apogee-therapeutics-inc/documents/sec-edgar-10-k-2026-03-02-apge-20251231-htm",
    "absolute_url": "https://spela.port0.org/company/apogee-therapeutics-inc/documents/sec-edgar-10-k-2026-03-02-apge-20251231-htm",
    "txt_url": "/company/apogee-therapeutics-inc/documents/sec-edgar-10-k-2026-03-02-apge-20251231-htm/fulltext.txt",
    "absolute_txt_url": "https://spela.port0.org/company/apogee-therapeutics-inc/documents/sec-edgar-10-k-2026-03-02-apge-20251231-htm/fulltext.txt",
    "parts": [
      {
        "number": 1,
        "url": "/company/apogee-therapeutics-inc/documents/sec-edgar-10-k-2026-03-02-apge-20251231-htm/part-001.html",
        "chars": 178948
      },
      {
        "number": 2,
        "url": "/company/apogee-therapeutics-inc/documents/sec-edgar-10-k-2026-03-02-apge-20251231-htm/part-002.html",
        "chars": 179198
      },
      {
        "number": 3,
        "url": "/company/apogee-therapeutics-inc/documents/sec-edgar-10-k-2026-03-02-apge-20251231-htm/part-003.html",
        "chars": 178445
      },
      {
        "number": 4,
        "url": "/company/apogee-therapeutics-inc/documents/sec-edgar-10-k-2026-03-02-apge-20251231-htm/part-004.html",
        "chars": 90901
      }
    ]
  },
  {
    "doc_id": "sec-edgar-8-k-2026-01-06-tm261950d1-8k-htm",
    "title": "8-K – 2026-01-06 – tm261950d1_8k.htm",
    "source": "SEC EDGAR",
    "source_class": "sec",
    "source_url": "https://www.sec.gov/Archives/edgar/data/1974640/000110465926001063/tm261950d1_8k.htm",
    "date": "2026-01-06",
    "period": "2026-01-06",
    "form_type": "8-K",
    "report_key": null,
    "filename": "tm261950d1_8k.htm",
    "text_chars": 11740,
    "sha256": "9cdce08caac5ae19d21f606f31a9b7b68c8ffb29bde6296df26f09e5c8373270",
    "url": "/company/apogee-therapeutics-inc/documents/sec-edgar-8-k-2026-01-06-tm261950d1-8k-htm",
    "absolute_url": "https://spela.port0.org/company/apogee-therapeutics-inc/documents/sec-edgar-8-k-2026-01-06-tm261950d1-8k-htm",
    "txt_url": "/company/apogee-therapeutics-inc/documents/sec-edgar-8-k-2026-01-06-tm261950d1-8k-htm/fulltext.txt",
    "absolute_txt_url": "https://spela.port0.org/company/apogee-therapeutics-inc/documents/sec-edgar-8-k-2026-01-06-tm261950d1-8k-htm/fulltext.txt",
    "parts": [
      {
        "number": 1,
        "url": "/company/apogee-therapeutics-inc/documents/sec-edgar-8-k-2026-01-06-tm261950d1-8k-htm/part-001.html",
        "chars": 11740
      }
    ]
  },
  {
    "doc_id": "sec-edgar-8-k-2025-11-10-apge-20251110-htm",
    "title": "8-K – 2025-11-10 – apge-20251110.htm",
    "source": "SEC EDGAR",
    "source_class": "sec",
    "source_url": "https://www.sec.gov/Archives/edgar/data/1974640/000119312525273250/apge-20251110.htm",
    "date": "2025-11-10",
    "period": "2025-11-10",
    "form_type": "8-K",
    "report_key": null,
    "filename": "apge-20251110.htm",
    "text_chars": 4463,
    "sha256": "fbbca606e8d8e3407a83efd78febbce3e345a52f244900f91b8aa6e80f3335be",
    "url": "/company/apogee-therapeutics-inc/documents/sec-edgar-8-k-2025-11-10-apge-20251110-htm",
    "absolute_url": "https://spela.port0.org/company/apogee-therapeutics-inc/documents/sec-edgar-8-k-2025-11-10-apge-20251110-htm",
    "txt_url": "/company/apogee-therapeutics-inc/documents/sec-edgar-8-k-2025-11-10-apge-20251110-htm/fulltext.txt",
    "absolute_txt_url": "https://spela.port0.org/company/apogee-therapeutics-inc/documents/sec-edgar-8-k-2025-11-10-apge-20251110-htm/fulltext.txt",
    "parts": [
      {
        "number": 1,
        "url": "/company/apogee-therapeutics-inc/documents/sec-edgar-8-k-2025-11-10-apge-20251110-htm/part-001.html",
        "chars": 4463
      }
    ]
  },
  {
    "doc_id": "sec-edgar-10-q-2025-11-10-apge-20250930-htm",
    "title": "10-Q – 2025-11-10 – apge-20250930.htm",
    "source": "SEC EDGAR",
    "source_class": "sec",
    "source_url": "https://www.sec.gov/Archives/edgar/data/1974640/000119312525273260/apge-20250930.htm",
    "date": "2025-11-10",
    "period": "2025-09-30",
    "form_type": "10-Q",
    "report_key": null,
    "filename": "apge-20250930.htm",
    "text_chars": 408947,
    "sha256": "50a855d5c18b1b2e0d7fac27c6932f4b04655836af4fe74291b2ce45fa85d984",
    "url": "/company/apogee-therapeutics-inc/documents/sec-edgar-10-q-2025-11-10-apge-20250930-htm",
    "absolute_url": "https://spela.port0.org/company/apogee-therapeutics-inc/documents/sec-edgar-10-q-2025-11-10-apge-20250930-htm",
    "txt_url": "/company/apogee-therapeutics-inc/documents/sec-edgar-10-q-2025-11-10-apge-20250930-htm/fulltext.txt",
    "absolute_txt_url": "https://spela.port0.org/company/apogee-therapeutics-inc/documents/sec-edgar-10-q-2025-11-10-apge-20250930-htm/fulltext.txt",
    "parts": [
      {
        "number": 1,
        "url": "/company/apogee-therapeutics-inc/documents/sec-edgar-10-q-2025-11-10-apge-20250930-htm/part-001.html",
        "chars": 178503
      },
      {
        "number": 2,
        "url": "/company/apogee-therapeutics-inc/documents/sec-edgar-10-q-2025-11-10-apge-20250930-htm/part-002.html",
        "chars": 179640
      },
      {
        "number": 3,
        "url": "/company/apogee-therapeutics-inc/documents/sec-edgar-10-q-2025-11-10-apge-20250930-htm/part-003.html",
        "chars": 50797
      }
    ]
  },
  {
    "doc_id": "sec-edgar-8-k-2025-10-10-tm2528385d1-8k-htm",
    "title": "8-K – 2025-10-10 – tm2528385d1_8k.htm",
    "source": "SEC EDGAR",
    "source_class": "sec",
    "source_url": "https://www.sec.gov/Archives/edgar/data/1974640/000110465925098487/tm2528385d1_8k.htm",
    "date": "2025-10-10",
    "period": "2025-10-08",
    "form_type": "8-K",
    "report_key": null,
    "filename": "tm2528385d1_8k.htm",
    "text_chars": 6996,
    "sha256": "dbd3dcbeab6bd106e3a89f8c9875f449a0e3e2e3010d903cfd7717fa08fe0d14",
    "url": "/company/apogee-therapeutics-inc/documents/sec-edgar-8-k-2025-10-10-tm2528385d1-8k-htm",
    "absolute_url": "https://spela.port0.org/company/apogee-therapeutics-inc/documents/sec-edgar-8-k-2025-10-10-tm2528385d1-8k-htm",
    "txt_url": "/company/apogee-therapeutics-inc/documents/sec-edgar-8-k-2025-10-10-tm2528385d1-8k-htm/fulltext.txt",
    "absolute_txt_url": "https://spela.port0.org/company/apogee-therapeutics-inc/documents/sec-edgar-8-k-2025-10-10-tm2528385d1-8k-htm/fulltext.txt",
    "parts": [
      {
        "number": 1,
        "url": "/company/apogee-therapeutics-inc/documents/sec-edgar-8-k-2025-10-10-tm2528385d1-8k-htm/part-001.html",
        "chars": 6996
      }
    ]
  },
  {
    "doc_id": "sec-edgar-8-k-2025-08-11-apge-20250811-htm",
    "title": "8-K – 2025-08-11 – apge-20250811.htm",
    "source": "SEC EDGAR",
    "source_class": "sec",
    "source_url": "https://www.sec.gov/Archives/edgar/data/1974640/000095017025106228/apge-20250811.htm",
    "date": "2025-08-11",
    "period": "2025-08-11",
    "form_type": "8-K",
    "report_key": null,
    "filename": "apge-20250811.htm",
    "text_chars": 3678,
    "sha256": "31feb86d01a9a76de375b15313a181864575b378f4689fd44d23d03982f206f7",
    "url": "/company/apogee-therapeutics-inc/documents/sec-edgar-8-k-2025-08-11-apge-20250811-htm",
    "absolute_url": "https://spela.port0.org/company/apogee-therapeutics-inc/documents/sec-edgar-8-k-2025-08-11-apge-20250811-htm",
    "txt_url": "/company/apogee-therapeutics-inc/documents/sec-edgar-8-k-2025-08-11-apge-20250811-htm/fulltext.txt",
    "absolute_txt_url": "https://spela.port0.org/company/apogee-therapeutics-inc/documents/sec-edgar-8-k-2025-08-11-apge-20250811-htm/fulltext.txt",
    "parts": [
      {
        "number": 1,
        "url": "/company/apogee-therapeutics-inc/documents/sec-edgar-8-k-2025-08-11-apge-20250811-htm/part-001.html",
        "chars": 3678
      }
    ]
  },
  {
    "doc_id": "sec-edgar-10-q-2025-08-11-apge-20250630-htm",
    "title": "10-Q – 2025-08-11 – apge-20250630.htm",
    "source": "SEC EDGAR",
    "source_class": "sec",
    "source_url": "https://www.sec.gov/Archives/edgar/data/1974640/000095017025106234/apge-20250630.htm",
    "date": "2025-08-11",
    "period": "2025-06-30",
    "form_type": "10-Q",
    "report_key": null,
    "filename": "apge-20250630.htm",
    "text_chars": 394753,
    "sha256": "e937ce6306c8f5fb880717d11664e32a13d8879a842364adf7d44d9ac4f3cf82",
    "url": "/company/apogee-therapeutics-inc/documents/sec-edgar-10-q-2025-08-11-apge-20250630-htm",
    "absolute_url": "https://spela.port0.org/company/apogee-therapeutics-inc/documents/sec-edgar-10-q-2025-08-11-apge-20250630-htm",
    "txt_url": "/company/apogee-therapeutics-inc/documents/sec-edgar-10-q-2025-08-11-apge-20250630-htm/fulltext.txt",
    "absolute_txt_url": "https://spela.port0.org/company/apogee-therapeutics-inc/documents/sec-edgar-10-q-2025-08-11-apge-20250630-htm/fulltext.txt",
    "parts": [
      {
        "number": 1,
        "url": "/company/apogee-therapeutics-inc/documents/sec-edgar-10-q-2025-08-11-apge-20250630-htm/part-001.html",
        "chars": 179027
      },
      {
        "number": 2,
        "url": "/company/apogee-therapeutics-inc/documents/sec-edgar-10-q-2025-08-11-apge-20250630-htm/part-002.html",
        "chars": 178910
      },
      {
        "number": 3,
        "url": "/company/apogee-therapeutics-inc/documents/sec-edgar-10-q-2025-08-11-apge-20250630-htm/part-003.html",
        "chars": 36806
      }
    ]
  }
]